• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Procept Biorobotics Corp (NQ: PRCT )

    67.33 +2.14 (+3.28%)
    Streaming Delayed Price Updated: 11:38 AM EDT, Jul 11, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Procept Biorobotics Corp

    < Previous 1 2 3 4 Next >
    You’ve Been Warned! 3 Robotics Stocks to Buy Now or Regret Forever.
    While AI is grabbing all the headlines right now, forward-thinking investors are snapping up these robotics stocks before they blast off. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    From Science Fiction to Reality: 3 Robotics Stocks for Automatic Riches
    Artificial intelligence companies have already soared over the past year. These robotics stocks could be the next big thing. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Unveiling 4 Analyst Insights On PROCEPT BioRobotics
    Via Benzinga
    PROCEPT BioRobotics: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 27, 2024
    Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
    Via Benzinga
    PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
    From PROCEPT BioRobotics
    Via GlobeNewswire
    Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
    Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH... 
    From PROCEPT BioRobotics
    Via GlobeNewswire
    Intuitive Surgical Builds On Its Robotic Surgery Prowess. But Challengers Are Coming.
    As new robotic surgery systems loom, Intuitive Surgical investors await a "game-changer." 
    Via Investor's Business Daily
    PROCEPT BioRobotics's Earnings: A Preview
    Via Benzinga
    Demystifying PROCEPT BioRobotics: Insights From 4 Analyst Reviews
    Via Benzinga
    PRCT Stock Earnings: PROCEPT BioRobotics Beats EPS, Beats Revenue for Q1 2024
    PRCT stock results show that PROCEPT BioRobotics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
    Japanese post market survey supports safety and efficacy of Aquablation therapy 
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
    Presentations include first published experience report of same-day discharge in an ambulatory surgical center, real-world data outcomes and 5-year data comparison between two FDA trials 
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
    From PROCEPT BioRobotics
    Via GlobeNewswire
    Truist Securities Maintains Buy Rating for PROCEPT BioRobotics: Here's What You Need To Know
    Via Benzinga
    PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2023 Results
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics to Present at the 44th Annual TD Cowen Health Care Conference in Boston
    From PROCEPT BioRobotics
    Via GlobeNewswire
    Procept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest'
    Procept BioRobotics Corp (NASDAQ: PRCT) shares are trading higher after the company announced fourth-quarter (Q4) FY23  
    Via Benzinga
    PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics Stock Scores Rising Relative Strength
    The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77. 
    Via Investor's Business Daily
    PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
    From PROCEPT BioRobotics
    Via GlobeNewswire
    The 7 Best Tech Stocks To Buy Now: October 2023
    Although the innovation sector got overheated, certain underappreciated ideas make up the best tech stocks to buy now. 
    Via InvestorPlace
    PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
    From PROCEPT BioRobotics
    Via GlobeNewswire
    The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
    From PROCEPT BioRobotics
    Via GlobeNewswire
    PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
    From PROCEPT BioRobotics
    Via GlobeNewswire
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.